Essential Premium

Biopharma Hedge Funds Cool After Breakout Year

Strong 2025 gains give way to uneven results as stock swings and clinical setbacks weigh on performance.

OpenAI Backers Include Hedge Fund Heavyweights Poised for IPO Payoff

Tiger Global, Coatue, and D1 are among the firms that have backed the ChatGPT maker over the years and stand to benefit as it nears an IPO.

Sponsored

What Could Be Next for the U.S. Dollar?

De-Dollarization Doesn’t Mean Capital Is Leaving America

Global investors are swapping Treasuries for U.S. ports, power grids, and data centers — turning financial claims into ownership of real assets.

Related Content

China Is Back in Portfolios — But Only for Investors Who Can Live With the Risk

Jonathan Kandell

Marc Rubinstein on the Hidden Fault Lines in Modern Finance

Michelle Celarier

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram